MY103191A - Novel substituted aminomethanediphosphonic acids - Google Patents
Novel substituted aminomethanediphosphonic acidsInfo
- Publication number
- MY103191A MY103191A MYPI87003074A MYPI19873074A MY103191A MY 103191 A MY103191 A MY 103191A MY PI87003074 A MYPI87003074 A MY PI87003074A MY PI19873074 A MYPI19873074 A MY PI19873074A MY 103191 A MY103191 A MY 103191A
- Authority
- MY
- Malaysia
- Prior art keywords
- formula
- phosphono
- atom
- lower alkyl
- group
- Prior art date
Links
- FRCICXIVPRNPLM-UHFFFAOYSA-N [amino(phosphono)methyl]phosphonic acid Chemical class OP(=O)(O)C(N)P(O)(O)=O FRCICXIVPRNPLM-UHFFFAOYSA-N 0.000 title 1
- -1 PHOSPHONO GROUP Chemical class 0.000 abstract 4
- 230000003913 calcium metabolism Effects 0.000 abstract 2
- 229910052736 halogen Inorganic materials 0.000 abstract 2
- 150000002367 halogens Chemical class 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical group [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical class [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000007513 acids Chemical class 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical class [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 abstract 1
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
- C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
- C07F9/65324—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/65392—Five-membered rings containing two nitrogen atoms
- C07F9/65397—Five-membered rings containing two nitrogen atoms having the two nitrogen atoms in positions 1 and 3
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Detergent Compositions (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Diaphragms For Electromechanical Transducers (AREA)
- Saccharide Compounds (AREA)
- Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
HETEROARYLAMINOMETHANEDIPHOSPHONIC ACIDS OF THE FORMULA(FORMULA. 1)IN WHICH R1 REPRESENTS AN OPTIONALLY BENZO-OR CYCLOHEXENO-FUSED 5-MEMBERED HETEROARYL RADICAL THAT CONTAINS, AS HETERO ATOM(S),EITHER FROM 2 TO 4 N-ATOMS OR 1 OR 2 N-ATOMS AS WELL AS 1 0-ATOM OR S-ATOM AND THAT IS UNSUBSTITUTED OR IS SUBSTITUTED BY LOWER ALKYL; BY PHENYL THAT IS UNSUBSTITUTED OR IS SUBSTITUTED BY LOWER ALKYL, LOWER ALKOXY AND/OR BY HALOGEN; BY LOWER ALKOXY; BY HYDROXY; BY DI-LOWER ALKYLAMINO; BY LOWER ALKYLTHIO AND/OR BY HALOGEN; AND R2 REPRESENTS HYDROGEN OR LOWER ALKYL, AND THEIR SALTS, HAVE A REGULATORY ACTION ON THE CALCIUM METABOLISM AND CAN BE USED AS ACTIVE INGREDIENTS IN MEDICAMENTS FOR THE TREATMENT OF ILLNESSES THAT CAN BE ATTRIBUTED TO DISORDERS OF THE CALCIUM METABOLISM. THEY ARE MANUFACTURED, FOR EXAMPLE, AS FOLLOWS: IN A COMPOUND OF THE FORMULA (FORMULA. 2)IN WHICH X1 REPRESENTS A FUNCTIONALLY MODIFIED PHOSPHONO GROUP X AND X2 REPRESENTS PHOSPHONO OR SIMILARLY REPRESENTS A FUNCTIONALLY MODIFIED PHOSPHONO GROUP X, THE GROUP(S) X IS(ARE) CONVERTED INTO FREE PHOSPHONO.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH466586 | 1986-11-21 |
Publications (1)
Publication Number | Publication Date |
---|---|
MY103191A true MY103191A (en) | 1993-05-29 |
Family
ID=4280333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI87003074A MY103191A (en) | 1986-11-21 | 1987-11-20 | Novel substituted aminomethanediphosphonic acids |
Country Status (21)
Country | Link |
---|---|
EP (1) | EP0274346B1 (en) |
JP (1) | JPS63150290A (en) |
KR (1) | KR880006217A (en) |
AT (1) | ATE61371T1 (en) |
AU (1) | AU605203B2 (en) |
CA (1) | CA1324383C (en) |
DD (1) | DD265900A5 (en) |
DE (1) | DE3768463D1 (en) |
DK (1) | DK168869B1 (en) |
ES (1) | ES2038693T3 (en) |
FI (1) | FI87653C (en) |
GR (1) | GR3001611T3 (en) |
HU (1) | HU201087B (en) |
IE (1) | IE60148B1 (en) |
IL (1) | IL84494A (en) |
MY (1) | MY103191A (en) |
NO (1) | NO170283C (en) |
NZ (1) | NZ222608A (en) |
PH (1) | PH23959A (en) |
PT (1) | PT86166B (en) |
ZA (1) | ZA878656B (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0282309A3 (en) * | 1987-03-11 | 1990-03-14 | Yamanouchi Pharmaceutical Co. Ltd. | Azole-aminomethylene bisphosphonic acid derivatives |
US5270365A (en) * | 1991-12-17 | 1993-12-14 | Merck & Co., Inc. | Prevention and treatment of periodontal disease with alendronate |
TW237386B (en) * | 1992-04-15 | 1995-01-01 | Ciba Geigy | |
EP0600834A1 (en) * | 1992-11-30 | 1994-06-08 | Ciba-Geigy Ag | Use of methanebisphosphonic acid derivatives for the manufacture of a medicament for fracture healing |
US5880111A (en) * | 1995-06-07 | 1999-03-09 | Farcasiu; Dan | Therapeutic derivations of diphosphonates |
ATE290871T1 (en) * | 1995-09-29 | 2005-04-15 | Novartis Pharma Gmbh | METHOD FOR TREATING NAVICULAR DISEASES IN HORSES |
DE10226420A1 (en) * | 2002-06-13 | 2004-01-15 | Eucro European Contract Research Gmbh & Co Kg | Procedure for the treatment of atherosclerosis |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS54135724A (en) * | 1978-04-11 | 1979-10-22 | Nissan Chem Ind Ltd | Preparation of amino-methylenedisulfonic acid derivative |
IL77243A (en) * | 1984-12-21 | 1996-11-14 | Procter & Gamble | Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds |
-
1987
- 1987-11-16 ES ES198787810665T patent/ES2038693T3/en not_active Expired - Lifetime
- 1987-11-16 AT AT87810665T patent/ATE61371T1/en not_active IP Right Cessation
- 1987-11-16 EP EP87810665A patent/EP0274346B1/en not_active Expired - Lifetime
- 1987-11-16 DE DE8787810665T patent/DE3768463D1/en not_active Expired - Lifetime
- 1987-11-16 IL IL84494A patent/IL84494A/en not_active IP Right Cessation
- 1987-11-18 PH PH36078A patent/PH23959A/en unknown
- 1987-11-18 FI FI875095A patent/FI87653C/en not_active IP Right Cessation
- 1987-11-18 CA CA000552085A patent/CA1324383C/en not_active Expired - Fee Related
- 1987-11-19 NZ NZ222608A patent/NZ222608A/en unknown
- 1987-11-19 DD DD87309213A patent/DD265900A5/en not_active IP Right Cessation
- 1987-11-19 ZA ZA878656A patent/ZA878656B/en unknown
- 1987-11-19 PT PT86166A patent/PT86166B/en not_active IP Right Cessation
- 1987-11-20 KR KR1019870013062A patent/KR880006217A/en not_active Application Discontinuation
- 1987-11-20 IE IE314787A patent/IE60148B1/en not_active IP Right Cessation
- 1987-11-20 JP JP62292196A patent/JPS63150290A/en active Pending
- 1987-11-20 NO NO874855A patent/NO170283C/en unknown
- 1987-11-20 AU AU81452/87A patent/AU605203B2/en not_active Ceased
- 1987-11-20 DK DK609387A patent/DK168869B1/en not_active IP Right Cessation
- 1987-11-20 HU HU875159A patent/HU201087B/en not_active IP Right Cessation
- 1987-11-20 MY MYPI87003074A patent/MY103191A/en unknown
-
1991
- 1991-03-15 GR GR90401110T patent/GR3001611T3/en unknown
Also Published As
Publication number | Publication date |
---|---|
ATE61371T1 (en) | 1991-03-15 |
IL84494A (en) | 1992-08-18 |
ES2038693T3 (en) | 1993-08-01 |
ZA878656B (en) | 1988-08-31 |
NO874855D0 (en) | 1987-11-20 |
EP0274346B1 (en) | 1991-03-06 |
KR880006217A (en) | 1988-07-22 |
PH23959A (en) | 1990-01-23 |
NZ222608A (en) | 1990-09-26 |
FI87653B (en) | 1992-10-30 |
JPS63150290A (en) | 1988-06-22 |
NO170283B (en) | 1992-06-22 |
IE60148B1 (en) | 1994-06-01 |
CA1324383C (en) | 1993-11-16 |
NO874855L (en) | 1988-05-24 |
EP0274346A1 (en) | 1988-07-13 |
FI875095A0 (en) | 1987-11-18 |
HU201087B (en) | 1990-09-28 |
DK168869B1 (en) | 1994-06-27 |
IE873147L (en) | 1988-05-21 |
DK609387A (en) | 1988-05-22 |
GR3001611T3 (en) | 1992-11-23 |
FI87653C (en) | 1993-02-10 |
DD265900A5 (en) | 1989-03-15 |
NO170283C (en) | 1992-09-30 |
FI875095A (en) | 1988-05-22 |
IL84494A0 (en) | 1988-04-29 |
PT86166B (en) | 1990-11-20 |
PT86166A (en) | 1987-12-01 |
AU605203B2 (en) | 1991-01-10 |
DK609387D0 (en) | 1987-11-20 |
DE3768463D1 (en) | 1991-04-11 |
HUT46329A (en) | 1988-10-28 |
AU8145287A (en) | 1988-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO173446C (en) | Analogous Procedures for the Preparation of New, Therapeutically Active, Substituted Alkandiphosphonic Acids | |
MY103191A (en) | Novel substituted aminomethanediphosphonic acids | |
ES8607235A1 (en) | 4-(Nitrophenyl)-tetrahydropyridines, process for their preparation and their application as pharmaceutical compounds. | |
TW357144B (en) | Substituted phosphinic compounds and their use as pharmaceuticals |